Tate & Lyle PLC
TATE: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| p>> | LOCK|gPpH | LOCK|#lxF$%X |
Tate & Lyle Earnings: Price Investments and Portfolio Repositioning Should Drive Volume Recovery
Tate & Lyle reported another 3% revenue decline on a pro forma basis for the fiscal year ending March 2026, while sales accelerated sequentially in the fourth quarter. Management acknowledged disappointing results due to soft demand but expects sales momentum to build in the future.
